AbbVie Price to Sales Ratio 2010-2019 | ABBV

Historical PS ratio values for AbbVie (ABBV) over the last 10 years. The current P/S ratio for AbbVie as of October 11, 2019 is .
AbbVie P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2019-10-14 73.76 3.41
2019-06-30 72.72 $21.65 3.36
2019-03-31 80.59 $21.35 3.77
2018-12-31 91.04 $21.05 4.33
2018-09-30 92.42 $20.50 4.51
2018-06-30 89.64 $19.43 4.61
2018-03-31 90.63 $18.50 4.90
2017-12-31 91.94 $17.61 5.22
2017-09-30 83.89 $16.95 4.95
2017-06-30 67.85 $16.51 4.11
2017-03-31 60.37 $16.12 3.74
2016-12-31 57.42 $15.71 3.66
2016-09-30 57.30 $15.45 3.71
2016-06-30 55.75 $15.10 3.69
2016-03-31 50.95 $14.50 3.51
2015-12-31 52.26 $13.97 3.74
2015-09-30 47.54 $13.45 3.54
2015-06-30 58.28 $12.99 4.49
2015-03-31 50.36 $12.70 3.97
2014-12-31 55.87 $12.40 4.50
2014-09-30 48.94 $12.20 4.01
2014-06-30 47.45 $11.99 3.96
2014-03-31 42.83 $11.84 3.62
2013-12-31 43.65 $11.70 3.73
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $108.861B $32.753B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $346.602B 15.10
Roche Holding AG (RHHBY) Switzerland $247.573B 0.00
Merck (MRK) United States $215.942B 17.76
Pfizer (PFE) United States $199.726B 11.76
Novartis AG (NVS) Switzerland $198.470B 17.08
Novo Nordisk (NVO) Denmark $121.313B 21.43
AstraZeneca (AZN) United Kingdom $114.344B 22.12
Sanofi (SNY) France $112.561B 13.83
GlaxoSmithKline (GSK) United Kingdom $105.206B 13.22
Eli Lilly (LLY) United States $104.614B 19.52
Bristol-Myers Squibb (BMY) United States $84.422B 11.97
Bayer (BAYRY) Germany $66.771B 9.73
H Lundbeck (HLUYY) Denmark $6.541B 9.44